We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+14.23%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$2.8B
AUM Growth
+$635M
Cap. Flow
+$218M
Cap. Flow %
7.8%
Top 10 Hldgs %
49.77%
Holding
313
New
122
Increased
18
Reduced
66
Closed
70

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$183M
2
ESGR
Enstar Group
ESGR
+$157M
3
BPMC
Blueprint Medicines
BPMC
+$138M
4
SKX
Skechers
SKX
+$137M
5
DNB
Dun & Bradstreet
DNB
+$129M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$208M
2
PDCO
Patterson Companies, Inc.
PDCO
+$149M
3
ATSG
Air Transport Services Group
ATSG
+$95M
4
PLYA
Playa Hotels & Resorts
PLYA
+$93.6M
5
SWI
SolarWinds Corporation Common Stock
SWI
+$90.9M

Sector Composition

Rank Sector Weight
1 Financials 32.76%
2 Healthcare 14.93%
3 Consumer Discretionary 10.31%
4 Industrials 7.94%
5 Technology 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESGR
1
DELISTED
Enstar Group
ESGR
$243M 8.67%
721,000
+468,669
+186% +$157M
SWTX
2
DELISTED
SpringWorks Therapeutics
SWTX
$193M 6.9%
+4,107,199
New +$183M
BPMC
3
DELISTED
Blueprint Medicines
BPMC
$171M 6.1%
+1,331,300
New +$138M
DNB
4
DELISTED
Dun & Bradstreet
DNB
$162M 5.79%
17,804,631
+14,409,994
+424% +$129M
SKX
5
DELISTED
Skechers
SKX
$151M 5.4%
+2,393,675
New +$137M
TGI
6
DELISTED
Triumph Group
TGI
$97.6M 3.49%
3,792,074
+3,299,494
+670% +$84.1M
AZEK
7
DELISTED
The AZEK Co
AZEK
$92.6M 3.31%
1,706,849
+713,190
+72% +$35.7M
MAG
8
DELISTED
MAG Silver
MAG
$91M 3.26%
+4,308,334
New +$76.6M
EVRI
9
DELISTED
Everi Holdings
EVRI
$82.1M 2.94%
5,760,076
+4,755,450
+473% +$66.5M
CHX
10
DELISTED
ChampionX
CHX
$61.2M 2.19%
2,464,373
+1,881,317
+323% +$47.4M
RDFN
11
DELISTED
Redfin
RDFN
$54.3M 1.94%
4,832,138
+4,263,784
+750% +$41.8M
AVDX
12
DELISTED
AvidXchange
AVDX
$50.2M 1.79%
+5,125,000
New +$46.2M
JNPR
13
DELISTED
Juniper Networks
JNPR
$43.9M 1.57%
+1,100,000
New +$39.4M
AGS
14
DELISTED
PlayAGS
AGS
$43.1M 1.54%
3,451,287
+2,772,700
+409% +$33.8M
ETWO
15
DELISTED
E2open Parent Holdings
ETWO
$42.7M 1.53%
+13,229,511
New +$34.8M
COOP
16
DELISTED
Mr. Cooper
COOP
$36.1M 1.29%
241,994
-33,006
-12% -$4.23M
VIGL
17
DELISTED
Vigil Neuroscience
VIGL
$23.9M 0.86%
+3,012,068
New +$13.5M
HONE
18
DELISTED
HarborOne Bancorp
HONE
$22.6M 0.81%
+1,936,513
New +$21.2M
TASK icon
19
TaskUs
TASK
$536M
$22.1M 0.79%
+1,317,902
New +$20.1M
EQX icon
20
Equinox Gold
EQX
$7.38B
$21.3M 0.76%
+3,675,732
New +$23.9M
ANSC
21
Agriculture & Natural Solutions Acquisition Corp
ANSC
$476M
$20.3M 0.73%
1,875,033
-345,522
-16% -$3.71M
DMAA
22
Drugs Made In America Acquisition Corp
DMAA
$18.6M 0.66%
1,822,450
-502
-0% -$5.08K
INZY
23
DELISTED
Inozyme Pharma
INZY
$17.3M 0.62%
+4,330,220
New +$10.7M
OYSEU
24
Oyster Enterprises II Acquisition Corp Units
OYSEU
$15.2M 0.54%
+1,499,883
New +$15.1M
UBER icon
25
Uber
UBER
$143B
$15M 0.54%
160,700
+85,800
+115% +$7.06M
1
2 3 4 5

Similar funds

GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SCB
Saudi Central Bank Riyadh, Saudi Arabia $4.72B AUM 29.46% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $4.73B AUM 58.9% 1-Year Est. Return
VDI
Vaughan David Investments Peoria, Illinois $4.73B AUM 19.55% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

Glazer Capital LLC's Q2 2025 Portfolio in Review

As of Q2 2025, Glazer Capital LLC held 313 positions worth $2.8B, up 29% from $2.16B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Glazer Capital LLC deployed $218M of net new capital in Q2 2025, opening 122 new positions and adding to 18 existing holdings. Its largest new stake was SpringWorks Therapeutics: 4,107,199 shares worth $193M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Kellanova, an estimated $78.8M trimmed.

  • Glazer Capital LLC's largest Q2 2025 buy was SpringWorks Therapeutics: 4,107,199 shares worth $193M.
  • Glazer Capital LLC added most to Enstar Group in Q2 2025, an estimated $157M increase.
  • Glazer Capital LLC's biggest Q2 2025 reduction was Kellanova, cutting an estimated $78.8M.
  • Glazer Capital LLC fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $208M.
  • Glazer Capital LLC's ten largest holdings make up 50% of its $2.8B portfolio in Q2 2025.
  • Glazer Capital LLC opened 122 new positions and closed 70 in Q2 2025.
  • Glazer Capital LLC's portfolio value rose 29% quarter-over-quarter to $2.8B.

Based on Glazer Capital LLC's 13F filing for Q2 2025, filed 14 Aug 2025.